We combine world-leading scientific and medical expertise with cutting-edge technical innovation, to improve diagnostic accuracy and enhance clinical care for cancer patients.
The company has developed its expertise since its establishment in 2022, building on decades of combined experience of its founders. We conduct research and development, certification and marketing of software solutions for molecular tumour classification based on DNA methylation profiling and machine learning.
Company Details
- Employees
- 9
- Founded
- -
- Address
- Heidelberg, De
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.epignostix.com
- Keywords
- Epigenetics, CNS tumours, Brain tumours, Pathology, Precision medicine, Artificial Intelligence.
- HQ
- Heidelberg
Heidelberg Epignostix Gmbh Questions
Heidelberg Epignostix Gmbh's website is http://www.epignostix.com
Heidelberg Epignostix Gmbh's LinkedIn profile is https://de.linkedin.com/company/heidelberg-epignostix
Heidelberg Epignostix Gmbh has
9 employees.
View email and phone details for 9
employees at Heidelberg Epignostix Gmbh.
Heidelberg Epignostix Gmbh's industry is
Biotechnology Research
Heidelberg Epignostix Gmbh's top competitors are
Varm,
Biolabs Heidelberg,
Dermafy Group,
Hopp Children's Cancer Center Heidelberg (Kitz),
Heidelberg Pharma Ag,
Carma Fund Management Gmbh,
Anavo Therapeutics Bv,
Infocus Therapeutics,
Biorn Life Science Cluster,
Marcley.
Heidelberg Epignostix Gmbh's categories are Biotechnology Research
Heidelberg Epignostix Gmbh's founding year is 2022
